Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8
Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8
巴克萊將Bright Health Gr的評級下調至減持,將目標股價上調至8美元
Barclays analyst Steve Valiquette downgrades Bright Health Gr (NYSE:BHG) from Overweight to Underweight and raises the price target from $4 to $8.
巴克萊分析師史蒂夫·瓦利奎特將Bright Health Gr(紐約證券交易所代碼:BHG)的評級從增持下調至減持,並將目標股價從4美元上調至8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。